Market Tracker

03/23 5:16pm ET

Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

53.18
Delayed Data
As of 3:59pm ET
 -0.075 / -0.14%
Today’s Change
31.38
Today|||52-Week Range
80.11
+42.03%
Year-to-Date

Today’s Trading

Previous close53.25
Today’s open53.94
Day’s range52.18 - 53.94
Volume845,099
Average volume (3 months)1,190,779
Market cap$4.6B
Dividend yield--
Data as of 3:59pm ET, 03/23/2017

Growth & Valuation

Earnings growth (last year)-38.84%
Earnings growth (this year)-7.07%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+14.75%
P/E ratioNM
Price/Sales67.96
Price/Book4.97

Competitors

 Today’s
change
Today’s
% change
GRFSGrifols SA+0.21+1.18%
MNKMallinckrodt Plc+0.64+1.50%
TAROTaro Pharmaceutical ...+1.96+1.71%
IONSIonis Pharmaceutical...-0.21-0.55%
Data as of 4:02pm ET, 03/23/2017

Financials

Next reporting dateMay 11, 2017
EPS forecast (this quarter)-$1.28
Annual revenue (last year)$47.2M
Annual profit (last year)-$410.1M
Net profit margin-869.63%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John M. Maraganore
President
Barry E. Greene
Corporate headquarters
Cambridge, Massachusetts

Forecasts